| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |